GSM Pharma Private Limited
About GSM Pharma Private Limited
Data last updated:
GSM Pharma Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2011PTC034563. Its GSTIN is 03AAECG0873E1Z1 (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Manjeet Kaur and Suman Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at He No 40 Phase – 5, Mohali, Punjab, India – 160055.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.6 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹11.35 Lakh (net margin -17.8%) and EBITDA of -₹11.16 Lakh (EBITDA margin -17.6%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 15% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
GSM Pharma Private Limited's registered office is in Mohali, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHe No 40 Phase – 5, Mohali, Punjab, India – 160055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of GSM Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of GSM Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of GSM Pharma Private Limited, buy the company report.
Financials of GSM Pharma Private Limited
FY 2025 filings availableGSM Pharma Private Limited reported revenue of ₹63.6 Lakh (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 22% fall in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.6% | ||||
| Net Profit Margin | -17.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GSM Pharma Private Limited, buy the company report.
Board of directors of GSM Pharma Private Limited
GSM Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjeet Kaur | Director | 05 Jan 2011 | 15 Years 9 Months | Current |
| Suman Devi | Director | 05 Jan 2011 | 15 Years 9 Months | Current |
| Gurpreet Kaur | Director | 05 Jan 2011 | 15 Years 9 Months | Current |
Peer comparison
GSM Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| GSM Pharma Private Limitedthis company | ₹63.6 Lakh (FY 2025) | -₹11.35 Lakh | -17.8% | -22.0% | Mohali, Punjab, India | |
| Bionisa Lifesciences Private Limited | ₹63.49 Lakh (FY 2018) | 47.0% | Chennai, Tamil Nadu, India | |||
| Welbeck Pharmaceuticals Private Limited | ₹63.48 Lakh (FY 2025) | -20.0% | New Delhi, Delhi, India | |||
| Black God Chemical Industries (OPC) Private Limited | ₹63.41 Lakh (FY 2024) | Mangalore, Karnataka, India |
To see the full peer comparison of GSM Pharma Private Limited, buy the company report.
Auditor
GSM Pharma Private Limited is audited by GAMBHIR KHURANA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAMBHIR KHURANA & ASSOCIATES | FY 2023 | 012599N |
Shareholding
The shareholding of GSM Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of GSM Pharma Private Limited, buy the company report.
Legal cases
GSM Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of GSM Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GSM Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
GSM Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAECG0873E1Z1 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of GSM Pharma Private Limited, buy the company report.
Recent activity
GSM Pharma Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Gurpreet Kaur was appointed as Director on 05 Jan 2011.
Frequently asked questions
GSM Pharma is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 January 2011 (15+ years old) and is registered under CIN U24232PB2011PTC034563.
GSM Pharma has 3 current directors:
- Manjeet Kaur - Director
- Suman Devi - Director
- Gurpreet Kaur - Director
The latest financial statements of GSM Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of GSM Pharma is 03AAECG0873E1Z1, registered in Punjab.
The CIN (Corporate Identification Number) of GSM Pharma is U24232PB2011PTC034563. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GSM Pharma has 1 court case on record: 1 filed against it.
GSM Pharma was incorporated on 05 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of GSM Pharma by revenue are Bionisa Lifesciences Private Limited, Welbeck Pharmaceuticals Private Limited, Black God Chemical Industries (OPC) Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (wholesale trading).
Gurpreet Kaur was appointed as Director on 05 Jan 2011. Manjeet Kaur was appointed as Director on 05 Jan 2011. Suman Devi was appointed as Director on 05 Jan 2011.
The registered office of GSM Pharma is at He No 40 Phase – 5, Mohali, Punjab, India – 160055.
GSM Pharma operates in the pharma industry, in the drug formulation and development segment.